Introduction {#s1}
============

As it is becoming increasingly clear that proteins populate a variety of 'intermediate' states during their function ([@bib16]; [@bib42]), it is essential to determine the structures of such states in addition to defining the native conformations. Protein intermediates are involved in folding, misfolding, and aggregation processes, as well as in events associated with molecular recognition, catalysis, and allostery ([@bib16]; [@bib42]; [@bib48]). These species are transient in nature and as such they have been difficult to characterise. Nuclear magnetic resonance (NMR) spectroscopy has emerged in this context as a powerful technique to define such states as exemplified by the characterisation of the structures of species involved in folding ([@bib26]), molecular recognition ([@bib44]), and aggregation ([@bib32]).

In the present paper, we describe a study of the mechanism involved in the process by which an enzyme releases its products. This is one of the three major steps in an enzymatic catalysis process ([@bib18]). In the first step, the enzyme forms a complex with the substrate. In the second step, the transition state of the reaction is reached within the favourable environment provided by the catalytic site enabling the conversion of the substrate into product. In the third step, which is often rate-limiting, the product is released and the enzyme returns to its original state. Each of these steps is usually rather complex and involves reaction intermediates, which are transient in nature and difficult to characterise.

In order to investigate the third step, we have studied here lysozyme, the first enzyme to be crystallised ([@bib4]), and whose structural properties have been characterised in great detail ([@bib4]; [@bib36]; [@bib1]; [@bib39]). The native structure of this enzyme is divided into a α domain (residues 1 to 38, and 86 to 130) and β domain (residues 39 to 85), containing primarily α-helical and β-sheet secondary structures, respectively ([@bib4]; [@bib36]; [@bib1]; [@bib39]). This enzyme degrades bacterial cell walls by catalysing the hydrolysis of the 1,4-β-linkages of the cell wall peptidoglycans, with a reaction that has been the object of intense scrutiny ([@bib9]; [@bib51]; [@bib38]; [@bib49]). According to the mechanism originally proposed by Phillips on the basis of his structure ([@bib36]), lysozyme binds to a peptidoglycan molecule in the binding site within the cleft between its two domains thus causing the substrate to adopt a strained conformation similar to that of the transition state of the hydrolysis. Here, we study the product release process. To this end, we used a well-characterised oligosaccharide product having an inhibitory effect on the enzyme, N,N\',N"-triacetylchitotriose (triNAG) ([@bib47]), which has been frequently used for studying lysozyme--product interactions ([@bib38]).

Results and discussion {#s2}
======================

In order to define the structural populations of human lysozyme in the presence and in the absence of an inhibitor, we measured ^15^N-^1^H residual dipolar couplings (RDCs) ([@bib45]; [@bib46]) in the ligand-free and ligand-bound states (see 'Materials and methods') and used them as structural restraints in molecular dynamics simulations ([@bib14]; [@bib30]). In this way, we determined two ensembles of structures of the enzyme representing, respectively, the ligand-free and the ligand-bound states of this protein. Our results indicate that large-scale concerted motions between the α and β domains of the enzyme generate an intermediate state involved in the release of the product.

The use of RDCs as structural restraints assists the conformational sampling in molecular dynamics simulations in order to estimate the free-energy landscape of a protein, as recently shown with hen lysozyme for which a large body of experimental data were used for validation purposes ([@bib15]). This approach enables the translation of the experimental measurements into structures according to the principle of maximum entropy ([@bib37]; [@bib8]; [@bib40]). A number of methods to employ NMR measurements of RDCs for the characterisation of the structure and dynamics of proteins have been proposed ([@bib11]; [@bib6]; [@bib28]). Since these approaches have generally been used to assess dynamic events of relatively small amplitude, it was necessary to derive a means of extending these methods to enable the description of the large conformational interconversions associated with the function of many protein molecules.

The strategy that we have used for this purpose relies on the ability to extract from time and spatially averaged data the contributions to the experimental observables that come from the low-population states present as a result of conformational fluctuations. Intermediate states determined in this way have been already described using paramagnetic resonance enhancement (PRE) ([@bib44]) and RDC ([@bib12]; [@bib15]) measurements, complementing approaches in which NMR parameters specific for these states are obtained directly, in particular by relaxation--dispersion methods ([@bib25], [@bib26]; [@bib5]; [@bib32]). By applying this approach using RDCs to human lysozyme, we generated a structural ensemble representing the free state of this enzyme that reveals large breathing motions between the α and β domains ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplements 1,2](#fig1s1 fig1s2){ref-type="fig"}). This motion, which influences the mutual orientation of the two domains thereby altering the structure of the catalytic pocket at their interface, can be accounted for by defining a 'breathing' angle θ between the α-domain, the hinge region and the β-domain ([@bib15]) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}).10.7554/eLife.02777.003Figure 1.Comparison of the free-energy landscapes of human lysozyme in the free state (**A**) and in the bound state with triNAG (**B**).The bound state exhibits a ground state (the 'locked state') and an additional local minimum with about 13% population (the 'unlocked state'), which represents an intermediate in the release of the product of the enzymatic reaction. Free-energy landscapes are shown as function of the 'breathing' angle θ and of the RMSD from the X-ray structure, which was calculated on the Cα atoms by including secondary structure regions only, of a human lysozyme variant in complex with triNAG (PDB code 1BB5); free-energy landscapes were obtained as −k~B~TlnH(θ, RMSD), where H(θ, RMSD) is the number of times conformations with specific θ and RMSD values was sampled during the simulations ([@bib15]).**DOI:** [http://dx.doi.org/10.7554/eLife.02777.003](10.7554/eLife.02777.003)10.7554/eLife.02777.004Figure 1---figure supplement 1.Assignments of the ^1^H-^15^N HSQC spectra of the free and triNAG-bound states of human lysozyme.The x-axis represents the ^1^H (in ppm) dimension and the y-axis represents the ^15^N (in ppm) dimension.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.004](10.7554/eLife.02777.004)10.7554/eLife.02777.005Figure 1---figure supplement 2.Extracts of ^1^H-^15^N HSQC spectra showing the titration of triNAG to human lysozyme for selected residues showing significant chemical shift changes upon binding.Depending on the individual residues, the time scale of exchange is fast or intermediate. Blue: free state (f); yellow: 0.5 equivalents of sugar; red: 1.1 equivalents; green: 2.4 equivalents; blue: 10 equivalents, corresponding to the bound state (b). The x-axis represents the ^1^H (in ppm) dimension and the y-axis represents the ^15^N dimension (in ppm).**DOI:** [http://dx.doi.org/10.7554/eLife.02777.005](10.7554/eLife.02777.005)10.7554/eLife.02777.006Figure 1---figure supplement 3.Illustration of the breathing angle θ of lysozyme ([@bib15]), which accounts for the large-amplitude motion between the α-domain and β-domain of lysozyme and is computed from the centres of mass of Cα-atoms from three protein regions ([@bib15]).Region 1 (in the α-domain) spans residues 28--31 and 111--114 (in red), region 2 (in the hinge region) spans residues 90--93 (in yellow), and region 3 (in the β-domain) spans residues 44, 45, 51, and 52 (in green).**DOI:** [http://dx.doi.org/10.7554/eLife.02777.006](10.7554/eLife.02777.006)10.7554/eLife.02777.007Figure 1---figure supplement 4.(**A**, **B**) Experimentally measured ^15^N-^1^H residual dipolar couplings (RDCs) of human lysozyme in the free state (**A**) and the triNAG-bound state (**B**).(**C**, **D**) Representation of the regions that are mostly affected by triNAG binding in the steric (**C**) and electrostatic (**D**) RDC measurements (red indicates small changes and blue indicates large changes).**DOI:** [http://dx.doi.org/10.7554/eLife.02777.007](10.7554/eLife.02777.007)10.7554/eLife.02777.008Figure 1---figure supplement 5.Validation of the RDC-refined structural ensembles determined in this work representing the free and triNAG-bound states of human lysozyme.(**A**) Comparison between calculated and experimental RDCs (black circles for the steric medium and red circles for the electrostatic medium); the Q factors at 0.10 in both cases. (**B**) Comparison between experimental (black) and calculated (red) ^3^J HN-Hα scalar couplings; the RMSD value is 0.49 Hz. (**C**-**G**) Comparison between experimental and calculated chemical shifts, which we obtained by using the Sparta + method ([@bib43]): Cα (**C**), Cβ (**D**), N (**E**), Hα (**F**), and HN (**G**); the RMSD values (in ppm) are 0.90, 0.82, 1.90, 0.16, and 0.24 for Cα, Cβ, N, Hα, and HN, respectively. (**H**) Distributions of the satisfied (about 93%, in green) and violated (about 7%, in orange) NOEs in the individual structures of the ensemble.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.008](10.7554/eLife.02777.008)

In order to compare the free and bound states of the enzyme, we measured the RDCs also in the bound state ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figures supplements 1 and 2](#fig1s1 fig1s2){ref-type="fig"}). While in the free state the free-energy landscape is characterised by a single basin ([Figure 1A](#fig1){ref-type="fig"}), in the bound state a second local minimum appears ([Figure 1B](#fig1){ref-type="fig"}). This change, which reflects the differences in the RDC data of the free and bound states, corresponds to a wider distribution of values of the θ angle in the bound state compared with the free state ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). The bound state ensemble was validated using NOEs, J-couplings, chemical shifts and RDCs ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). The relative populations of the ground and excited states are comparable to those that we have studied previously using the method adopted here ([@bib13]; [@bib14]; [@bib12]; [@bib15]).

Having in mind the release of the product, we designate the global free energy minimum observed in this study as the 'locked state' (i.e., release incompetent), which is centred at θ values of about 58° and Cα-RMSD values of about 0.9 Å from the X-ray structure of the complex (calculated by considering secondary structure elements only), and the other free energy minimum, which has about a 13% population under the conditions of our experiments, defined as the 'unlocked state' (i.e., release competent, [Figure 1B](#fig1){ref-type="fig"}). The unlocked state is a compact conformation that differs from the locked state by a global motion in which the α and β subunits become closer, with a θ value of about 49° in the centre of the basin. This motion generates particularly distorted structures with global RMSD values of about 1.5 Å from the X-ray structure. The angle θ provides a simple and effective reaction coordinate to describe the effect of triNAG binding on the energy landscape of human lysozyme ([Figure 2A](#fig2){ref-type="fig"}), which clearly illustrates how the protein is able to explore closed conformations (i.e., θ \< 50°) upon ligand binding.10.7554/eLife.02777.009Figure 2.Analysis of the interactions that stabilise the intermediate state in the release of the product (the 'unlocked state').(**A**) Free-energy landscape as a function of the angle θ. (**B**) Potential energy landscape, *E*~*pot*~, of lysozyme in the free state; *E*~*pot*~ represents the contribution of the force field used in the simulations, that is, the total force field without the RDC restraint term (see 'Materials and methods'). (**C**) Potential energy landscape, *E*~*pot*~, of the lysozyme-triNAG bound state. (**D**) Structure of the 'locked state'. (**E**) Structure of the 'unlocked state'.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.009](10.7554/eLife.02777.009)

In the structural ensemble representing the complex between human lysozyme and triNAG, unlocked conformations are characterised by less favourable intermolecular Coulomb and van der Waals interactions than those found in the locked state ([Figure 2B--E](#fig2){ref-type="fig"}). A comparison between the locked and unlocked conformations indicates that this difference corresponds to specific interactions between the substrate and the binding pocket ([Figure 2D](#fig2){ref-type="fig"}), which include hydrophobic interactions between a methyl group of triNAG and the side-chain of W109, as well as hydrogen bonds between the ligand and the main chain amide group of N60 and the side chains of W64 and Q104. These interactions are present in essentially all the structures in the ensemble representing the locked state, while they are absent in the structures in the ensemble of the unlocked state. Indeed, because of a partial displacement of the ligand from the binding pocket, the unlocked conformations lose the tight interactions that are stabilised in the locked state and gain new interactions on the external surface of the protein. These interactions, which mainly involve hydrogen bonds between donor and acceptor groups from the ligand and the protein surface, are highly variable and heterogeneous in the unlocked conformations.

Overall, this analysis of the structural ensembles of human lysozyme suggests that, as a consequence of a concerted conformational transition, the enzyme explores conformations in which the specific and tight intermolecular interactions with the substrate in its locked state are largely lost in favour of the formation of weak and non-specific interactions in its unlocked state. This transition is favoured by large-scale conformational motions in which the α and β domains become closer, thus suggesting that these motions are employed by the enzyme to modulate the affinity with the ligand. The unlocked state therefore represents an intermediate state for product release. In this view ([Figure 3](#fig3){ref-type="fig"}), the enzyme product complex (EP) populates transiently an intermediate state (EP\*) that favours the release of the product (E + P). Thus, the analysis of the structural ensembles that we have determined provides evidence that large-scale conformational transitions are employed by enzymes along their catalytic cycles including key events in the product release step, which often represents the rate-limiting step that governs the turnover of the enzyme. The difficulty for enzymes to release the products can arise from the fact that typically the latter have similar physico-chemical characteristics to the substrates and therefore maintain a significant affinity for the enzyme.10.7554/eLife.02777.010Figure 3.Schematic illustration of the process of product release.The product (P) is released by the enzyme (E) in a process that begins in the ground (or 'locked') state of the complex (EP), visits a metastable (or 'unlocked') intermediate state (EP\*) and reaches the unbound state (E + P). The interactions in the 'locked state' (EP) and in the 'unlocked state' (EP\*) are shown in light blue.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.010](10.7554/eLife.02777.010)

To test the possibility that the structure that we have determined of the unlocked state represents an intermediate state in the release of the product, we compared in detail the energetic contributions that stabilise the locked and unlocked states and identified a stabilising hydrogen bond that can be formed only in the unlocked state ([Figure 4A](#fig4){ref-type="fig"}), which involves side-chain atoms of residue N44 in the β-domain and residue E35 in the α-domain. These two residues are too far away from each other in the locked state to form a hydrogen bond ([Figure 4B](#fig4){ref-type="fig"}), and therefore this interaction is characteristic only of the unlocked conformation. This finding suggests that this hydrogen bond provides a specific interaction by which one could selectively target the stability of the EP\* intermediate. To this end, we rationally designed the N44A single-amino acid mutation to verify if the ability of the enzyme to release the products is indeed altered by preventing the formation of the hydrogen bond that stabilises the unlocked state.10.7554/eLife.02777.011Figure 4.Experimental assessment of the role of the intermediate state determined in this work in the product release process.(**A**) Structure of the unlocked state illustrating the hydrogen bond between side chains of N44 and E35 that stabilises this intermediate species. (**B**) The hydrogen bond is not formed in the locked state because N44 and E35 are too far apart. (**C**) The N44A variant, which lacks the hydrogen bond donor, is unable to form this hydrogen bond, thus destabilising the intermediate state and inhibiting the release of the product. The decrease of the ability of the N44A mutant to release triNAG has been assessed by surface plasmon resonance (SPR) experiments. (**D**) Cellular assay of lysozyme activity. The N44A variant has an intermediate activity between wild type and the control E35D variant.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.011](10.7554/eLife.02777.011)10.7554/eLife.02777.012Figure 4---figure supplement 1.Comparison of the ^1^H-^15^N HSQC spectra of WT (black) and N44A mutant (red).**DOI:** [http://dx.doi.org/10.7554/eLife.02777.012](10.7554/eLife.02777.012)10.7554/eLife.02777.013Figure 4---figure supplement 2.Comparison of the free-energy landscapes of wild-type (red) and N44A mutant (black) lysozyme.In the N44A mutant, the unlocked state (see also [Figure 1](#fig1){ref-type="fig"}) is absent. Free-energy landscapes were obtained as described in [Figure 1](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.013](10.7554/eLife.02777.013)10.7554/eLife.02777.014Figure 4---figure supplement 3.Study of the N46Q/V110Q mutant.(**A**) Illustration of the engineered N46Q/V110Q glutamine--glutamine interactions. (**B**) The ^1^H-^15^N-HSQC spectrum of the N46Q/V110Q mutant shows that the mutation does not affect the structural properties of the mutant (see also [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). (**C**) The increase in the ability of the N46Q/V110Q mutant to release triNAG has been assessed by surface plasmon resonance (SPR) experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.02777.014](10.7554/eLife.02777.014)

Comparison of the ^1^H-^15^N-HSQC spectra of the wild-type and the N44A variant of human lysozyme shows that the mutation does not affect the structural properties of the mutant in the native state ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). This result was expected as the mutation does not modify interactions present in the native state but was designed explicitly to perturb a hydrogen bond in the intermediate state. The ability of the N44A variant to release triNAG from its bound state was assessed by surface plasmon resonance (SPR) experiments ([Figure 4C](#fig4){ref-type="fig"}). By using a double-referenced single chain model (see 'Materials and methods'), we estimated that the destabilisation of the intermediate in the N44A mutant reduces the k~off~ by a factor 3, while changing the K~d~ by a factor 1/3. The variation of a factor 2 of the k~on~ suggests that the pathways of capture and release are not completely distinct and thus perturbing the pathway for release affects in part also that of capture. These results are consistent with our prediction that the N44A mutation affects the stability of the EP\* intermediate, that is, of the unlocked state. Finally, we tested the catalytic efficiency of the wild-type and N44A mutant by using a cellular assay (see 'Materials and methods'), and compared these results with those obtained for an inactive mutational variant lacking the catalytic residue (E35D). The results ([Figure 4D](#fig4){ref-type="fig"}) show that the N44A variant has an intermediate activity between wild type and the totally inactive control E35D variant, which is again consistent with the prediction that the mutation of asparagine to alanine of residue 44 would reduce the efficiency of the product release in such a way to affect the catalytic activity of the enzyme. Finally, to verify that the N44A modified the free-energy landscape of lysozyme by reducing the population of the unlocked state, we performed ^15^N-^1^H RDC measurements on the N44A mutant and carried out restrained molecular dynamics simulations to determine its free-energy landscape. The results (see [Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}) demonstrate that the unlocked state is not appreciably populated in the N44A mutant.

To further validate the conclusion that the structure that we have determined of the unlocked state represents a release intermediate, we designed a second mutational variant to stabilise the unlocked state, rather than destabilising it as the N44A mutation. In the new mutant, N46Q/V110Q, a strong glutamine--glutamine interaction is inserted with the purpose to stabilise the 'unlocked' state in its conformation ([Figure 4---figure supplement 3A](#fig4s3){ref-type="fig"}). We have verified the folding of the mutant by NMR ([Figure 4---figure supplement 3B](#fig4s3){ref-type="fig"}) and measured the binding constants of the ligand for the unlocked state by SPR to show that it corresponds to a weaker binding affinity ([Figure 4---figure supplement 3C](#fig4s3){ref-type="fig"}). While the K~d~ of the wild type is about 9 μM, the K~d~ of the N46Q/V110Q mutant is high almost beyond detection, indicating that the mutant essentially does not bind the substrate. These experimentally measured binding constants are consistent with the observation that, considering that the free energy of the free state is the same, the binding free energy of the locked state is larger than that of the unlocked state because the free energy of the former is lower than that of the latter ([Figure 1](#fig1){ref-type="fig"}).

Conclusions {#s2-1}
-----------

We have presented the atomic resolution structure of an intermediate associated with the product release in an enzymatic reaction. We have validated this structure by identifying a distinctive structural characteristic of this state, a transient hydrogen bond between the side-chains of residues N44 and E35. As this interaction stabilises the intermediate state but not the ground state, we introduced a mutational variant (N44A) that, by removing specifically the hydrogen bond, reduces the stability of the intermediate state but not that of the ground state and thus inhibits the release process. Our results provide an illustration of the manner in which conformational fluctuations can play a central role in enzymatic reactions by creating low-population intermediate states that facilitate the challenging step of release of the products of the catalytic reaction.

Materials and methods {#s3}
=====================

Sample preparation {#s3-1}
------------------

Human lysozyme was expressed in *Pichia pastoris* and purified on an ion exchange column, as previously described ([@bib22]). ^15^N ammonium sulfate and ^13^C methanol were used to ^15^N and ^13^C label the protein, respectively. NMR experiments were carried out using a 700 MHz spectrometer at 37°C in a buffer at pH 5.0 containing 20 mM potassium phosphate and 10% D~2~O; the pH was re-adjusted after the addition of the protein. Protein concentrations were in the range of 200--350 μM. For the measurements of the bound state, N,N′,N"-triacetylchitotriose (triNAG) sugar was purchased from Sigma and dissolved in water to constitute a concentrated stock solution.

Assignment of NMR spectra {#s3-2}
-------------------------

For the assignment of the free state at pH 5.0 and 37°C, we used a previously published assignment ([@bib33]; [@bib20]), which was confirmed using HNCA measurements, which was run with a spectral width of 1561 Hz and 68 points in the ^15^N dimension, and a spectral width of 5456 Hz and 64 points in the ^13^C dimension ([@bib19]). In total, 126 backbone amides were assigned in the ^1^H-^15^N spectrum.

For the full assignment of human lysozyme bound to triNAG, we performed titrations of ^1^H-^15^N HSQC spectra of a 200 μM sample of ^15^N human lysozyme, which were recorded using progressive concentration of the ligand (0, 0.3, 0.5, 0.8, 1.1, 1.6, 2.4, 3.1, 5.2, and 10 equivalents), allowing us to sample different points along the binding curve. HSQC spectra were recorded with a spectral width of 1621 Hz and 128 points in the ^15^N dimension ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Additional information was obtained using HNCA and HNCACB experiments of a triNAG-saturated human lysozyme sample ([@bib19]; [@bib31]). The HNCA experiment was carried out with the same settings as for the free state (see above). The HNCACB experiment was carried out with a spectral width of 1561 Hz and 68 points in the ^15^N dimension and with a spectral width of 13,210 Hz and 72 points in the ^13^C dimension. These complementary data allowed us to obtain the full assignment of the ^1^H-^15^N spectra ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Residual dipolar coupling measurements {#s3-3}
--------------------------------------

Residual dipolar couplings (RDCs) were measured by orienting the free and triNAG-bound states in two different bicelle solutions, neutral and charged ([@bib34]; [@bib41]). The neutral bicelle solution contained 5% wt/vol of a mixture of DMPC and DHPC (q = 2.9), whereas CTAB was used to create a positively charged solution of 10% wt/vol of the (DMPC:DHPC:CTAB) = (2.9:1:0.2) composition. Splitting of the ^2^H signal was recorded before and after the IPAP experiments, to ensure that alignment had remained constant during the course of the NMR experiment. IPAP experiments were recorded on the isotropic sample as well as on the two anisotropic samples (neutral and charged) ([@bib35]). These experiments were performed using a spectral width of 2447 Hz with 320 points in the indirect ^15^N dimension for the in-phase (IP) or anti-phase (AP) spectra. J-couplings were extracted in each medium and RDCs were derived, discarding overlapping and poorly defined peaks. For the free state, we extracted 109 RDCs in the steric medium and 110 in the charged medium; 109 RDCs were extracted for the bound state, both for steric and charged media.

^3^J scalar coupling measurements {#s3-4}
---------------------------------

^3^J HNHα couplings were obtained using HNHA experiments ([@bib50]), which were performed on the free and bound states using a 700 MHz spectrometer and a spectral width of 1454 Hz with 68 points in ^15^N and 9800 Hz with 72--80 points in the indirect ^1^H dimension. The ^3^J HNHα couplings were extracted using the ratio of intensities of cross- (I~X~) and diagonal (I~D~) peaks ([@bib27])$$\text{I}_{\text{X}}/\text{I}_{\text{D}} = - \tan^{2}\left( 2\text{Π}\text{ξ}^{3}\text{J} \right)$$with ξ = 13.05 ms.

Errors in the ^3^J HNHα coupling values were based either on a 5% uncertainty or on the noise level for cross-peaks with intensities below the RMS noise of the HNHA spectrum, estimated using Sparky (Goddard, T. D., and D. G. Kneller. SPARKY 3. University of California, San Francisco, 2004). Errors on intensities were propagated according to [Equation (1)](#equ1){ref-type="disp-formula"} to yield the error on ^3^J HNHα couplings. Residues with overlapping diagonal peaks were discarded, as well as glycine residues.

Molecular dynamics simulations {#s3-5}
------------------------------

As a starting structure for the ligand-free state, we used the crystal structure of human lysozyme at 1.9 Å resolution (PDB code 2ZIJ). For the bound state, we used the crystal structure of the human lysozyme A96L variant bound to triNAG at 1.8 Å resolution (PDB code 1BB5). This structure was modelled by mutating back residue 96 from L to A, as in the wild-type sequence. Molecular dynamics simulations were performed by using AMBER99SB with corrections on backbone ([@bib3]) and side chains ([@bib29]) dihedral angles as the force field (*E*^*FF*^) for the protein. triNAG was modelled using the GLYCAM06 force field ([@bib24]). The protein and protein/triNAG systems were solvated using the TIP3P water model ([@bib23]). A time step of 2 fs was used together with LINCS constraints ([@bib21]). Systems were energy minimised and equilibrated with positional restrained simulations of 20 ns, in which the heavy atoms of the protein and triNAG molecules were restrained to their Cartesian coordinates. For the free state, the resulting system box after equilibration was 5.55 × 6.16 × 5.56 nm^3^, with 5698 water molecules for a total of 19,123 atoms. For the bound state, the resulting system box after equilibration was 6.15 × 5.62 × 5.99 nm^3^, with 6131 water molecules for a total of 20,509 atoms.

The simulations were performed in the NPT ensemble by weak coupling the pressure and temperature with external baths. Temperature coupling was performed with the v-rescale method ([@bib7]) with a coupling constant of 0.1 ps. The pressure was kept constant using the Berendsen method ([@bib2]), with a coupling constant of 1.0 ps and at a reference pressure of 1 bar. The isotropic compressibility value was set to 4.5 × 10^−5^ bar^−1^. Electrostatic interactions were treated by using the particle mesh Ewald method ([@bib17]).

Molecular dynamics simulations with RDC restraints {#s3-6}
--------------------------------------------------

We used replica-averaged RDC restraints in molecular dynamics simulations ([@bib14]; [@bib30]; [@bib12]; [@bib15]). This method has been tested for its ability to sample interdomain motions in proteins ([@bib14]; [@bib15]), as well as in multiple conformational states in fast exchange in the NMR measurements ([@bib12]). A recent study was carried to generate accurate ensembles of hen egg white lysozyme using RDC measured under the same conditions of the present work ([@bib15]). This investigation has defined the sampling method that we have used here to characterise the conformational properties of lysozyme using RDC restraints. The accuracy of the resulting ensemble was benchmarked using a large variety of NMR observables, including eight sets of RDCs. Briefly, in this approach ([@bib14]; [@bib15]), the structural information provided by RDC measurements is imposed to restrain the molecular dynamics simulations by adding a term, *E*^*RDC*^, to a standard molecular mechanics force field, *E*^*Pot*^:$$E^{Tot} = E^{Pot} + E^{RDC}.$$

The resulting force field, *E*^*Tot*^, is employed in the integration of the equations of motion. In this work, the restraint term, *E*^*RDC*^, is given by [@bib14]; [@bib15]):$$E^{RDC} = \alpha\sum_{i}\left( {D^{\text{exp}} - D^{calc}} \right)^{2},$$where *α* is the weight of the restraint term, and *D*^*exp*^ and *D*^*calc*^ are the experimental and calculated RDCs, respectively. The RDC of a given bond vector is calculated as ([@bib14]; [@bib15]):$$D^{calc} = \frac{1}{M}\sum_{m}D_{m},$$where *m* runs over the *M* replicas and *D*~*m*~ is the RDC of replica *m*, which is given by:$$D = D_{max}\sum\limits_{ij}\left\langle A_{ij} \right\rangle\text{cos}\varphi_{i}\text{cos}\varphi_{j},$$where $\varphi_{i}$ and $\varphi_{j}$ are the angles between the internuclear vector and the molecular reference frame, the indices *i* and *j* run over the three Cartesian coordinates, *x*, *y*, and *z*, and $\left\langle A_{ij} \right\rangle$ is the *(i,j)* component of the alignment tensor.

The use of replica-averaged molecular dynamics simulations enables one to generate an ensemble of conformations compatible with the experimental data according to the maximum entropy principle ([@bib37]; [@bib8]; [@bib40]), at least in the limit of large *M* and *α*. We have previously shown ([@bib8]), however, that it is possible to effectively achieve this limit even if the values of *M* and *α* remain relatively small and thus obtain conformational ensembles that provide a good agreement between experimental and calculated observables. Following these procedures, we used here *M = 16* and for the weight, *α*, we first carried out an initial equilibration simulation at 310 K, during which the agreement between the calculated and experimental data was allowed to converge by gradually raising α to the largest possible value that did not generate numerical instabilities. Subsequently, we performed a series of 50 cycles of simulated annealing between 310 and 500 K to sample the conformational space. Each cycle was carried out for a total of 250 ps (125,000 molecular dynamics steps). For each cycle, we collected 24,000 structures (1 per ps in the final 50 ps of the final 30 cycles of each of the 16 replicas). These structures were employed for the analyses reported in this study.

The alignment tensor is calculated from the shape and charge of the protein molecule using a procedure recently described ([@bib30]). We adopted such an approach here rather than the more commonly used singular value decomposition (SVD) method ([@bib11]; [@bib10]) because in the presence of conformational fluctuations of relatively large amplitude, such as those exhibited by hen lysozyme, the SVD method, when used in combination with the replica-averaging procedure of [Equations 2](#equ2){ref-type="disp-formula"}--[5](#equ5){ref-type="disp-formula"}, is less effective in capturing the motions of a protein ([@bib15]). The reason is that the SVD method does not necessarily provide the actual alignment tensor of a given structure but rather the alignment tensor that generates the RDC values in the closest agreement with the experimental ones and hence is less well suited in describing the specific differences between the structures considered in the averaging procedure in [Equation (3)](#equ3){ref-type="disp-formula"} ([@bib30]; [@bib15]).

This structure-based method was used here to calculate the orientations of lysozyme in two alignment media, one steric (DMPC/DHPC) and one electrostatic (DMPC/DHPC/CTAB). The Q factors for the refined ensembles of the free and bound states of human lysozyme were 0.10 in both cases.

In addition to the previous extensive benchmarks performed on the structural ensembles of the hen egg white lysozyme ([@bib12]), which were obtained using the same protocol employed in this work, we performed here a set of additional validations based on NMR measurements not used as restraints in the simulations and by comparing the resulting experimental values with those back-calculated from our ensemble of human lysozyme ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}).

Mutagenesis {#s3-7}
-----------

N44A mutation and E35D or D53N (control mutations) were introduced into the pPIC9/HuLys wt by using *QuikChange* XL II mutagenesis kit (Qiagen, Venlo, The Netherlands). The pPIC9 plasmid containing the point mutations of HuLys cDNA was linearised by digestion with StuI. Transformation into *Pichia pastoris* GS115 was performed by using *Pichia* EasyComp Transformation Kit (Life Technologies), according to manufacturer\'s instructions. Cell colonies were screened for lysozyme expression level by quantifying by NuPAGE analysis the amount of lysozyme produced in 10-ml mini-cultures. Protein expression and purification were performed as previously reported ([@bib22]). Protein purity exceeded 95% as estimated by NuPAGE analysis. Protein concentrations were determined by absorbance measurements at 280 nm using theoretical extinction coefficients calculated with Expasy ProtParam.

Surface plasmon resonance {#s3-8}
-------------------------

Surface plasmon resonance (SPR) experiments were performed using a Biacore 3000 system (GE Healthcare). CM5 sensor chip surfaces were activated by using an amine coupling kit (GE Healthcare). WT and N44A lysozyme variants were immobilised to the activated surfaces by amine coupling at a density of 2500--3000 resonance units (RU). Single chain kinetic experiments were performed at 25°C using a flow rate of 20 µl/min in 50 mM phosphate pH 6.2, 100 mM NaCl. Serial dilutions (200 µM, 100 µM, 50 µM, 25 µM, and 12.5 µM) of N,N′,N′′-Triacetylchitotriose (Tri-NAG, Sigma Aldrich) were sequentially injected every 700 s using a contact time of 250 s for each injection. Data fitting was performed with the single chain kinetic module provided with the Biaevaluation software (Biacore GE lifesciences).

Cellular assay of lysozyme activity {#s3-9}
-----------------------------------

Hydrolase activity assay was performed using *Micrococcus lysodeikticus* cells (Sigma Aldrich) as the substrate. Cells of *Micrococcus* were suspended at 0.3 mg/ml in 100 mM potassium phosphate, pH 6.2, shortly before the assay. The decrease of Absorbance at 450 nm was monitored at 25⁰C in the presence of 20 nM lysozyme variants.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Structure of a low-population intermediate state in the release of an enzyme product" for consideration at *eLife*. Your article has been handled by John Kuriyan (Senior editor and Reviewing editor) and three additional reviewers.

The reviewers agree that this is a fine piece of work that is overall very well performed and the conclusions logically drawn. The results further highlight the importance of characterizing lowly populated conformational states. Nevertheless, the reviewers are also in agreement that some additional data would be needed to make the conclusions more compelling. We ask that you respond by email to the points raised below, paying particular attention to the major points. Your response should tell us how you could address these issues in a realistic timeframe. A final decision on your paper will be made after the reviewers have considered your response.

Ensembles of structures of the enzyme lysozyme were determined by combining NMR-detected RDCs and MD simulations to structurally characterize an intermediate species along the enzymatic pathway. In particular, the paper analyzes NMR data using a method called ensemble-average molecular dynamics simulations. The analysis was carried out on the ligand-free and the ligand-bound states of the enzyme. The data show that the ground state (∼87%) exists in the locked state (the one wherein the product is still bound to the enzyme) and in equilibrium with an energetically excited state (populated ∼13% of the time), which allows product release (termed the unlocked state). The two states are related by an opening/closure of the ligand-binding cleft by ∼10 degrees.

The unlocked state with the bound ligand is a compact conformation that differs from the locked state by a global motion, with global RMSD values of about 1.5 Å relative to the X-ray structure. The unlocked conformations lose the tight interactions that are stabilized in the locked state and gain new interactions on the external surface of the protein. These interactions, which mainly involve hydrogen bonds between donors and acceptors groups from the ligand and the protein surface, are highly variable and heterogeneous in the unlocked conformations. It is hypothesized that the unlocked state represents an intermediate state that is critical for fast product release. The authors then identified a stabilizing hydrogen bond that can be formed only in the unlocked state ([Figure 4A](#fig4){ref-type="fig"}), which involves side-chain atoms of residue N44 E35. The ability of the N44A variant to release triNAG from its bound state was assessed by SPR. The dissociation constants of the wild-type and the N44A variant to be, respectively, 4.19 sec-1 and 1.31 sec-1. This provides a degree of cross-validation that this state is in fact important for release.

Major points:

1\) One weakness identified by the reviewers is that it is only a speculation that the ligand is more loosely bound in the "unlocked" state. The authors provide no firm basis for this assertion. The paper provides only one mutant to test the key concept that there is an unlocked state. Based on the available information, it seems that one should be able to design a mutant that stabilizes the unlocked state. If so, then one could: (1) confirm the existence of the state directly by NMR, (2) measure the binding constants (kinetics and equilibrium) of the ligand for the unlocked state by SPR to show that it is indeed faster and with a weaker binding affinity. From a computational point of view, it should be possible to calculate the binding free energy of the ligand for the locked and unlocked state, and show that the affinity is reduced in the latter. Doing this additional work is substantial, but it would really demonstrate that the conclusions are correct.

2\) It might be thought that the RDC approach for detecting rare states would be inferior to other approaches, like relaxation dispersion or PREs. In the case of relaxation dispersion one relies on the fact that the minor state is only transiently formed so that its effective linewidth is very large. Thus, the exchange process gives rise to a net increased linewidth in the ground state that can be detected. In a similar manner, as long as the excited state brings the NMR probes close to the spin label, a PRE effect is observed in the ground state. By contrast, however, RDCs contain information about each state and it is unlikely that the rare state has RDCs that are so different relative to the ground state, making this approach potentially less sensitive. Can the authors comment on the sensitivity of their method in general to studies of rare conformations? How much lower than 15% can one go and how robust are the states that are determined?

3\) In this regard, the authors do address the robustness with their N44A mutant and this is an important control. It would be very interesting to record RDC on this mutant (free form) and show that the same profile as in [Figure 1A](#fig1){ref-type="fig"} is observed. Second, it would then be of great interest to add the product to the N44A mutant, measure RDC and repeat the calculations. One would predict that the rare conformer would become less populated, less than 15%, and that would provide further important proof of the methodology that jives with the functional (release) studies that they perform. These controls are not particularly onerous but they would be very convincing. At issue here to some extent is the reliability of RDCs for dynamics, and there has been much debate in the literature about this (especially when one considers the fact that methods for estimating RDCs from structure are only approximate, especially for electrostatic alignment, or methods for dealing with the effects of averaging between multi-states again can be complex). This work opens up an approach for looking at rare states, and further evidence of utility is important.

4\) Although not necessary, have the authors considered experiments to show that the initial binding step of substrate is unaffected by the N44A mutation, as would be predicted since the ground state is unaffected?
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Author response

*1) One weakness identified by the reviewers is that it is only a speculation that the ligand is more loosely bound in the "unlocked" state. The authors provide no firm basis for this assertion. The paper provides only one mutant to test the key concept that there is an unlocked state. Based on the available information, it seems that one should be able to design a mutant that stabilizes the unlocked state. If so, then one could: (1) confirm the existence of the state directly by NMR, (2) measure the binding constants (kinetics and equilibrium) of the ligand for the unlocked state by SPR to show that it is indeed faster and with a weaker binding affinity. From a computational point of view, it should be possible to calculate the binding free energy of the ligand for the locked and unlocked state, and show that the affinity is reduced in the latter. Doing this additional work is substantial, but it would really demonstrate that the conclusions are correct*.

We are grateful for these key suggestions. To take account of them, we have used the structure of the intermediate that we calculated to rationally design a new mutant meant to stabilise the unlocked state. In the new mutant, N46Q/V110Q, a strong glutamine-glutamine interaction is inserted with the purpose to effectively block the 'unlocked' state in its conformation (see [Figure 4--figure supplement 3A](#fig4s3){ref-type="fig"}).

We have verified the folding of the new mutant by NMR (see [Figure 4--figure supplement 3B](#fig4s3){ref-type="fig"}) and measured the binding constants of the ligand for the unlocked state by SPR to show that it corresponds to a weaker binding affinity (see [Figure 4--figure supplement 3C](#fig4s3){ref-type="fig"}).Variantk~on~ (M^-1^s^-1^)St. Errk~off~ (s^-1^)St. ErrWT7516.7E-042E-05N46Q/V110Q13nd1.4E+04nd

While the Kd of the wild type is about 9 uM, the Kd of the N46Q/V110Q mutant is high almost beyond detection, indicating that the mutant essentially does not bind the substrate. These experimentally measured binding constants are consistent with the observation that, considering that the free energy of the free state is the same, the binding free energy of the locked state is larger than that of the unlocked state because the free energy of the former is lower than that of the latter ([Figure 1](#fig1){ref-type="fig"}).

In order to validate the design procedure of the mutational variants with modified stability of the unlocked state, we have performed new RDC measurements of the N44A variant and used them to determine the corresponding free energy landscape (see [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}). We have not repeated this NMR analysis for the N46Q/V110Q mutant since the measurements of the binding constants provided already clear indications of the success of the design procedure. If the editors, however, believe that we should perform the additional NMR analysis also on the second mutant we will be happy to do so.

*2) It might be thought that the RDC approach for detecting rare states would be inferior to other approaches, like relaxation dispersion or PREs. In the case of relaxation dispersion one relies on the fact that the minor state is only transiently formed so that its effective linewidth is very large. Thus, the exchange process gives rise to a net increased linewidth in the ground state that can be detected. In a similar manner, as long as the excited state brings the NMR probes close to the spin label, a PRE effect is observed in the ground state. By contrast, however, RDCs contain information about each state and it is unlikely that the rare state has RDCs that are so different relative to the ground state, making this approach potentially less sensitive. Can the authors comment on the sensitivity of their method in general to studies of rare conformations? How much lower than 15% can one go and how robust are the states that are determined*?

We recognise the importance of these considerations. In the revised version of the manuscript we have addressed the issue of the sensitivity of the approach that we have used, and briefly reviewed previous publications in which we have demonstrated that it can be employed to characterise populations as low as those studied here (De Simone et al., JACS 131, 3810-3811, 2009; J. Chem., Theor. Comput., 7, 4189-4195, 2011; Biochemistry 52, 6684-6694, 2013; Biochemistry 52, 6480-6486, 2013).

*3) In this regard, the authors do address the robustness with their N44A mutant and this is an important control. It would be very interesting to record RDC on this mutant (free form) and show that the same profile as in* [*Figure 1A*](#fig1){ref-type="fig"} *is observed. Second, it would then be of great interest to add the product to the N44A mutant, measure RDC and repeat the calculations. One would predict that the rare conformer would become less populated, less than 15%, and that would provide further important proof of the methodology that jives with the functional (release) studies that they perform. These controls are not particularly onerous but they would be very convincing. At issue here to some extent is the reliability of RDCs for dynamics, and there has been much debate in the literature about this (especially when one considers the fact that methods for estimating RDCs from structure are only approximate, especially for electrostatic alignment, or methods for dealing with the effects of averaging between multi-states again can be complex). This work opens up an approach for looking at rare states, and further evidence of utility is important*.

To take account of this point, we performed additional 1H-15N RDC measurements on the N44A mutant and carried out new restrained molecular dynamics simulations to determine its free energy landscape. The new results (see [Figure 4--figure supplement 2a](#fig4s2){ref-type="fig"}) demonstrate that the unlocked state is not populated in the N44A mutant, as expected from its rational design and the measurement of the binding constants reported in the original version of the manuscript.

*4) Although not necessary, have the authors considered experiments to show that the initial binding step of substrate is unaffected by the N44A mutation, as would be predicted since the ground state is unaffected*?

We have checked whether the binding step is affected by the N44A mutation.Variantk~on~ (M^-1^s^-1^)St. Errk~off~ (s^-1^)St. ErrWT7516.7E-042E-05N44A38.70.72.5E-043E-05

The destabilisation of the intermediate in the N44A mutant brings down the k~off~ by a factor 3, while changing the K~d~ by a factor 1/3. The k~on~ varies by a factor 2, indicating that the pathways of capture and release are not completely distinct and thus perturbing the pathway for release affects in part also that of capture.
